Poster Abstracts • OFID 2017:4 (Suppl 1) • S623 Mycobacterium tuberculosis (Mtb) and outcomes of TB depending on Mtb strains' genotypes among different age groups of TB patients.
Methods. Blood culture data from patients tested by Verigene BC-GN from June 2015 -July 2016 from the Detroit Medical Center and University of Maryland Medical Center were retrospectively reviewed and evaluated for incidence of missed GNs in GN BSIs. Missed GNs entailed those not detected in the tested sample and those that grew in a separate complementary positive blood culture bottle collected but not tested using Verigene BC-GN. For blood culture sets with missed GNs, potential clinical significance was evaluated.
Results. A total of 1,003 sets of GN blood cultures were reviewed. Fifty-seven (5.6%) were determined to be polymicrobial GN BSIs by traditional microbiological culture methods. Verigene BC-GN did not identify one or more GNs in 37 cases (65% of polymicrobial GN BSIs; 3.7% of total GN BSIs.); 25 were missed by the probe in the tested culture and 12 where missed due to isolation in the complementary blood culture bottle that was not tested by Verigene BC-GN. While potentially inappropriate de-escalation of antibiotic therapy could have occurred in 18 (31.5%) of polymicrobial GN BSIs, this represented only 1.8% of total GN BSIs.
Conclusion. Current practices utilizing Verigene BC-GN can result in the omission of undetected GNs in over half of polymicrobial GN BSIs. These misses were a combination of technology and workflow limitations. The potential for inappropriate de-escalation of antibiotic therapy in the entire cohort, however, was infrequent (<2% of total cases). Background. Early diagnosis of BSI and appropriate antimicrobials are crucial; additionally avoidance of overly broad antibiotics is important to curb the development of resistance. Rapid molecular approaches are costly and have spectrum limitations. In our prior pilot study simple phenotypic RDDDT provided accurate susceptibility data for GNB over 24 hours earlier than conventional methods. This follow up pilot study evaluated RDDDT plus prompt stewardship intervention to decrease the time to optimal antimicrobial therapy.
Methods. GNB positive blood cultures (BACTEC) were inoculated by expressed swab to MH agar plates. 12 antibiotic discs were applied. After at least 8 hr incubation, results in conjunction with MALDI-TOF speciation, were reported to EMR at 9am or 3pm. After review the ID Fellow contacted the primary MD to escalate, deescalate, or continue current antibiotics. Results of the RDDDT were compared with routine VITEK and assessed as complete agreement (CA) or as very major (VM), major (M), minor (MI) discrepancies. Times to susceptibility, RDDDT based antibiotic optimization, and VITEK reports were assessed. Time to VITEK based optimization was obtained from the prior baseline pilot study.
Results. 164 patients with GNB were evaluated. 1688 individual RDDDT readings, including 297 ESBL and 66 CRE were compared with VITEK. RDDDT had 85% CA and 0.4% VM, 2.3% M, 13% MI discrepancies. The median time from BC positivity to RDDDT report was 17.5 hours vs. 46 hours for VITEK. Of 164 patients, 162 were assessed clinically. Of those, 72 (44%) required antibiotic change with median time to optimization 21 hours based on RDDDT vs. 71 hours based on prior baseline VITEK.
Conclusion. RDDDT coupled with prompt stewardship intervention provided a safe and reliable strategy to improve time to antibiotic optimization with savings of ~2 days compared with standard VITEK reporting. Furthermore, RDDDT is simple and applicable worldwide, especially in resource limited areas. 
